Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Farmers Insurance
Covington
Harvard Business School
Cipla
Argus Health
Medtronic
Chubb
Merck

Generated: June 24, 2018

DrugPatentWatch Database Preview

DISIPAL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Disipal, and when can generic versions of Disipal launch?

Disipal is a drug marketed by 3M and is included in one NDA.

The generic ingredient in DISIPAL is orphenadrine hydrochloride. There are nine drug master file entries for this compound. Additional details are available on the orphenadrine hydrochloride profile page.
Summary for DISIPAL
Drug patent expirations by year for DISIPAL
Synonyms for DISIPAL
(+/-)-orphenadrine hydrochloride
2-Dimethylaminoethyl 2-methylbenzhydryl ether hydrochloride
341-69-5
AC1L1TBY
AC1Q3BLK
AC1Q3DQC
AKOS024307520
AN-23409
API0003697
beta-Dimethylaminoethyl 2-methylbenzhydryl ether hydrochloride
BF 5930
BG 5930
BS 5930
CAS-341-69-5
CCG-220239
CCG-222188
CHEBI:60902
CHEMBL1201023
CPD000058999
CS-4723
D02599
Dimethyl-[2-(2-methyl-benzhydryloxy)-aethyl]-amin
dimethyl-[2-(2-methyl-benzhydryloxy)-ethyl]-amine
dimethyl({2-[(2-methylphenyl)(phenyl)methoxy]ethyl})amine hydrochloride
dimethyl{2-[(2-methylphenyl)phenylmethoxy]ethyl}amine, chloride
Disipal (TN)
Disipal hydrochloride
Disipal, Orphenadrinhydrochlorid
DSSTox_CID_5815
DSSTox_GSID_25815
DSSTox_RID_77934
DTXSID5025815
EINECS 206-435-4
Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, hydrochloride
Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, hydrochloride (9CI)
Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-, hydrochloride
Ethanamine,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-, hydrochloride
ETHYLAMINE, N,N-DIMETHYL-2-((o-METHYL-alpha-PHENYLBENZYL)OXY)-, HYDROCHLORIDE
Ethylamine,N-dimethyl-2-[.alpha.-(o-tolyl)benzyloxy]-, hydrochloride
Ethylamine,N-dimethyl-2-[(o-methyl-.alpha.-phenylbenzyl)oxy]-, hydrochloride
Ethylamine,N-dimethyl-2-[phenyl-(o-tolyl)methoxy]-, hydrochloride
EU-0100884
FT-0631984
HMS1568P19
HY-B1126
J-019475
LP00884
LS-1218
MCULE-1907411306
Mebedrol
Mefenamin hydrochloride
Mephenamin
Mephenamin forte
Mephenamin hydrochloride
Mephenamine hydrochloride
MFCD00012480
MLS000069427
MLS001148572
MLS002548882
MLS006011645
MolPort-002-111-239
N,N-Dimethyl-2-(2-methylbenzhydryloxy)ethylamine hydrochloride
N,N-Dimethyl-2-(o-methyl-.alpha.-phenylbenzyloxy)ethylamine hydrochloride
N,N-Dimethyl-2-(o-methyl-alpha-phenylbenzyloxy)ethylamine hydrochloride
N,N-Dimethyl-2-[.alpha.-(o-tolyl)benzyloxy]ethylamine hydrochloride
N,N-Dimethyl-2-[(.alpha.-o-tolylbenzyl)oxy]ethylamine hydrochloride
N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine hydrochloride
N,N-dimethyl-2-[(2-methylphenyl)-phenylmethoxy]ethanamine;hydrochloride
N,N-dimethyl-2-[o-tolyl(phenyl)methoxy]ethanamine hydrochloride
NC00465
NCGC00089814-04
NCGC00094204-01
NCGC00094204-02
NCGC00255176-01
NCGC00261569-01
NSC 82357
NSC-82357
NSC82357
O 3752
o-Methyldiphenhydramine hydrochloride
O0406
Opera_ID_658
Orfenadrin hydrochloride
Orphenadrine (Chloride)
Orphenadrine (hydrochloride)
Orphenadrine Chloride
Orphenadrine for peak identification, European Pharmacopoeia (EP) Reference Standard
Orphenadrine HCl
Orphenadrine hydrochloride
Orphenadrine hydrochloride, >=98.0% (AT)
Orphenadrine hydrochloride, European Pharmacopoeia (EP) Reference Standard
orphenadrine*HCl
Orphenedrine hydrochloride
Prestwick_663
REGID_for_CID_9568
SAM002264628
SCHEMBL1235378
SMR000058999
SR-01000002975
SR-01000002975-2
ST50320118
Tox21_301927
Tox21_500884
WLN: 1N1 & 2OYR & R B1 & GH
WLN: 1N1&2OYR&R B1 &GH

US Patents and Regulatory Information for DISIPAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m DISIPAL orphenadrine hydrochloride TABLET;ORAL 010653-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Queensland Health
Boehringer Ingelheim
Daiichi Sankyo
Johnson and Johnson
McKinsey
QuintilesIMS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.